Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[A new lignan from rhizome of Stellera chamaejasme].
Liu SN, He J, Wang XX, Ma BZ, Zhang WK, Xu JK. Liu SN, et al. Zhongguo Zhong Yao Za Zhi. 2018 Apr;43(8):1649-1653. doi: 10.19540/j.cnki.cjcmm.20180116.003. Zhongguo Zhong Yao Za Zhi. 2018. PMID: 29751712 Chinese.
[Chemical constituents from ripe fruit of Cornus officinalis].
Ye XS, He J, Zhang JL, Pang XB, Zhang L, Qiao HY, Pan XG, Zhang J, Liu SN, Zhang WK, Xu JK. Ye XS, et al. Among authors: liu sn. Zhongguo Zhong Yao Za Zhi. 2016 Dec;41(24):4605-4609. doi: 10.4268/cjcmm20162419. Zhongguo Zhong Yao Za Zhi. 2016. PMID: 28936844 Chinese.
Dual mutations in the whitefly nicotinic acetylcholine receptor β1 subunit confer target-site resistance to multiple neonicotinoid insecticides.
Yin C, O'Reilly AO, Liu SN, Du TH, Gong PP, Zhang CJ, Wei XG, Yang J, Huang MJ, Fu BL, Liang JJ, Xue H, Hu JY, Ji Y, He C, Du H, Wang C, Zhang R, Tan QM, Lu HT, Xie W, Chu D, Zhou XG, Nauen R, Gui LY, Bass C, Yang X, Zhang YJ. Yin C, et al. Among authors: liu sn. PLoS Genet. 2024 Feb 20;20(2):e1011163. doi: 10.1371/journal.pgen.1011163. eCollection 2024 Feb. PLoS Genet. 2024. PMID: 38377137 Free PMC article.
Corrigendum to 'IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications': [Annals of Oncology 34 (2023) p693-702].
Burotto M, Zvirbule Z, Mochalova A, Runglodvatana Y, Herraez-Baranda L, Liu SN, Chan P, Shearer-Kang E, Liu X, Tosti N, Zanghi JA, Leutgeb B, Felip E. Burotto M, et al. Among authors: liu sn. Ann Oncol. 2024 May;35(5):482. doi: 10.1016/j.annonc.2023.12.005. Epub 2024 Jan 8. Ann Oncol. 2024. PMID: 38195363 No abstract available.
165 results